Literature DB >> 12600231

Stress and radiation-induced activation of multiple intracellular signaling pathways.

Paul Dent1, Adly Yacoub, Joseph Contessa, Ruben Caron, George Amorino, Kristoffer Valerie, Michael P Hagan, Steven Grant, Rupert Schmidt-Ullrich.   

Abstract

Exposure of cells to a variety of stresses induces compensatory activations of multiple intracellular signaling pathways. These activations can play critical roles in controlling cell survival and repopulation effects in a stress-specific and cell type-dependent manner. Some stress-induced signaling pathways are those normally activated by mitogens such as the EGFR/RAS/PI3K-MAPK pathway. Other pathways activated by stresses such as ionizing radiation include those downstream of death receptors, including pro-caspases and the transcription factor NFKB. This review will attempt to describe some of the complex network of signals induced by ionizing radiation and other cellular stresses in animal cells, with particular attention to signaling by growth factor and death receptors. This includes radiation-induced signaling via the EGFR and IGFI-R to the PI3K, MAPK, JNK, and p38 pathways as well as FAS-R and TNF-R signaling to pro-caspases and NFKB. The roles of autocrine ligands in the responses of cells and bystander cells to radiation and cellular stresses will also be discussed. Based on the data currently available, it appears that radiation can simultaneously activate multiple signaling pathways in cells. Reactive oxygen and nitrogen species may play an important role in this process by inhibiting protein tyrosine phosphatase activity. The ability of radiation to activate signaling pathways may depend on the expression of growth factor receptors, autocrine factors, RAS mutation, and PTEN expression. In other words, just because pathway X is activated by radiation in one cell type does not mean that pathway X will be activated in a different cell type. Radiation-induced signaling through growth factor receptors such as the EGFR may provide radioprotective signals through multiple downstream pathways. In some cell types, enhanced basal signaling by proto-oncogenes such as RAS may provide a radioprotective signal. In many cell types, this may be through PI3K, in others potentially by NFKB or MAPK. Receptor signaling is often dependent on autocrine factors, and synthesis of autocrine factors will have an impact on the amount of radiation-induced pathway activity. For example, cells expressing TGFalpha and HB-EGF will generate protection primarily through EGFR. Heregulin and neuregulins will generate protective signals through ERBB4/ERBB3. The impact on radiation-induced signaling of other autocrine and paracrine ligands such as TGFbeta and interleukin 6 is likely to be as complicated as described above for the ERBB receptors. Copyright 2003 by Radiation Research Society

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12600231     DOI: 10.1667/0033-7587(2003)159[0283:sariao]2.0.co;2

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  143 in total

1.  Inhibition of radiation-induced DNA repair and prosurvival pathways contributes to vorinostat-mediated radiosensitization of pancreatic cancer cells.

Authors:  Amit Deorukhkar; Shujun Shentu; Hee Chul Park; Parmeswaran Diagaradjane; Vinay Puduvalli; Bharat Aggarwal; Sushovan Guha; Sunil Krishnan
Journal:  Pancreas       Date:  2010-11       Impact factor: 3.327

2.  Exercise, sleep quality, and mediators of sleep in breast and prostate cancer patients receiving radiation therapy.

Authors:  Lisa K Sprod; Oxana G Palesh; Michelle C Janelsins; Luke J Peppone; Charles E Heckler; M Jacob Adams; Gary R Morrow; Karen M Mustian
Journal:  Community Oncol       Date:  2010-10

3.  Cediranib enhances control of wild type EGFR and EGFRvIII-expressing gliomas through potentiating temozolomide, but not through radiosensitization: implications for the clinic.

Authors:  Phyllis R Wachsberger; Richard Yaacov Lawrence; Yi Liu; Xu Xia; Barbara Andersen; Adam P Dicker
Journal:  J Neurooncol       Date:  2011-04-23       Impact factor: 4.130

4.  Epidermal growth factor receptor is activated by hyposmolarity and is an early signal modulating osmolyte efflux pathways in Swiss 3T3 fibroblasts.

Authors:  Rodrigo Franco; Ruth Lezama; Benito Ordaz; Herminia Pasantes-Morales
Journal:  Pflugers Arch       Date:  2004-01-16       Impact factor: 3.657

5.  ERBB3: Multifunctional enabler or primary actor in pancreatic cancer?

Authors:  Ralf Landgraf
Journal:  Cancer Biol Ther       Date:  2010-09-13       Impact factor: 4.742

Review 6.  Modifying radiation damage.

Authors:  Kwanghee Kim; William H McBride
Journal:  Curr Drug Targets       Date:  2010-11       Impact factor: 3.465

7.  The balance between initiation and promotion in radiation-induced murine carcinogenesis.

Authors:  Igor Shuryak; Robert L Ullrich; Rainer K Sachs; David J Brenner
Journal:  Radiat Res       Date:  2010-09       Impact factor: 2.841

8.  Transient genome-wide transcriptional response to low-dose ionizing radiation in vivo in humans.

Authors:  Susanne R Berglund; David M Rocke; Jian Dai; Chad W Schwietert; Alison Santana; Robin L Stern; Joerg Lehmann; Christine L Hartmann Siantar; Zelanna Goldberg
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-11-08       Impact factor: 7.038

9.  Prostaglandin E2 reduces radiation-induced epithelial apoptosis through a mechanism involving AKT activation and bax translocation.

Authors:  Teresa G Tessner; Filipe Muhale; Terrence E Riehl; Shrikant Anant; William F Stenson
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

Review 10.  Improving the efficacy of chemoradiation with targeted agents.

Authors:  Meredith A Morgan; Leslie A Parsels; Jonathan Maybaum; Theodore S Lawrence
Journal:  Cancer Discov       Date:  2014-02-18       Impact factor: 39.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.